Diabetic endothelial dysfunction: Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

Journal of Molecular Medicine

Volumn 79, Issue 8, 2001, Pages 437-448

  Soriano, Francisco ^a,b   Virág, László ^a,c   Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cytokine; Diabetes vascular; Free radicals; Nitric oxide; Oxidants

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROGEN; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE;

ARTICLE; DIABETIC ANGIOPATHY; DNA STRAND BREAKAGE; ELECTRON TRANSPORT; ENDOTHELIUM INJURY; ENERGY METABOLISM; ENZYME ACTIVATION; GENE EXPRESSION; GLYCOLYSIS;

ANIMALS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMANS; INFLAMMATION; NITRIC OXIDE; NITROGEN; OXYGEN; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 0034890040     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090100236     Document Type: Article

References (92)

1. Vascular function in Type 2 diabetes mellitus and pre-diabetes: The case for intrinsic endotheiopathy
2. Reducing the burden of diabetes: Managing cardiovascular disease
3. Endothelial dysfunction in diabetes
4. A new look at the heart in diabetes mellitus: From ailing to failing
5. Peripheral vascular disease and type 2 diabetes mellitus
6. Endothelium-derived relaxing factor: Discovery, early studies, and identification as nitric oxide
7. Nitric oxide: A unique endogenous signaling molecule in vascular biology
8. Endothelial dysfunctions: Common denominators in vascular disease
9. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes
10. Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus
11. Oxidative stress and diabetic vascular complications
12. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
13. Nitric oxide availability in diabetes mellitus
14. Increased nitrotyrosine in the diabetic placenta: Evidence for oxidative stress
15. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes
16. Antioxidants, diabetes and endothelial dysfunction
17. Nitric oxide as a secretory product of mammalian cells
18. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
19. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta
20. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals
21. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats
22. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats
23. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM
24. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension
25. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
26. Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and superoxide
27. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
28. The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury
29. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
30. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
31. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
32. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?
33. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction
34. Molecular and biochemical features of poly (ADP-ribose) metabolism
35. Mice lacking ADPRT and poly (ADP-ribosylation) develop normally but are susceptible to skin disease
36. (ADP-ribose) n participates in DNA excision repair
37. Role of poly (ADP-ribose) formation in DNA repair
38. Poly (ADP-ribosyl)ation of polynuclesomes causes relaxation of chromatin structure
39. Induction of murine teratocarcinoma cell differentiation by suppression of poly (ADP-ribose) synthesis
40. The expression of poly (ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex
41. Mechanism of c-fos induction by active oxygen
42. Synthesis of poly (adenosine diphosphate ribose) in synchronized Chinese hamster cells
43. Involvement of NAD-poly (ADP-ribose) metabolism in p53 regulation and its consequences
44. Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic trasnformation and in vitro poly (ADP-ribosyl)ation of nuclear proteins in human fibroblasts
45. DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite
46. Endogenous peroxynitrite is involved in the inhibition of cellular respiration in immunostimulated J774.2 macrophages
47. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitite
48. Peroxynitrite causes energy depletion and increases permeability via activation of poly-ADP ribosyl synthetase in pulmonary epithelial cells
49. Poly (ADP-ribose) synthetase mediates increased permeability induced by peroxynitrite in Caco-2BBe cells
50. ADP-ribosylation
51. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity
52. Endothelial dysfunction in endotoxic shock: Importance of the activation of poly (ADP ribose) synthetase by peroxynitrite
53. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation
54. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
55. Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase in vitro and in vivo models of stroke
56. Tankyrase, a poly (ADP-ribose) polymerase at human telomeres
57. PARP-2, A novel mammalian DNA damage-dependent poly (ADP-ribose) polymerase
58. Characterization of sPARP-1
59. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthetase
60. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
61. Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly (ADP-ribose) synthetase activation
62. Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death
63. Regulation of components of the inflammatory response by 5-iodo-6-amino-1:2-benzopyrone, an inhibitor of poly (ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways
64. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter
65. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation
66. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice
67. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury
68. Blockade of poly (ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis
69. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1 beta-induced nitric oxide synthase expression in pancreatic beta cells
70. Effects of inhibitors of ADP-ribosylation on macrophage activation
71. Peroxynitrite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide
72. Misregulation of gene expression in primary fibroblasts lacking poly (ADP-ribose) polymerase
73. Increased adhesion of neutrophils to retinal vascular endothelial cells exposed to hyperosmolarity
74. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C
75. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion
76. Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated Mongolian gerbils
77. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes
78. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: Role of NO synthase?
79. Oxidant-induced cytotoxicity: A challenge for metabolic modulation
80. Oxygen radicals in intestinal ischemia and reperfusion
81. Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
82. Evidence for poly (ADP-ribose) polymerase activation in the diabetic retina
83. Increased single strand breaks in DNA of lymphocytes from diabetic subjects
84. High glucose induces DNA damage in cultured human endothelial cells
85. Inhibitors of poly (adenosine diphosphate ribose) polymerase induce sister chromatid exchanges
86. Chromosomal aberrations in PARP (-/-) mice: Genome stabilization in immortalized cells by reintroduction of poly (ADP-ribose) polymerase cDNA
87. Roles of poly (ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
88. Poly (ADP-ribosyl)ation as a fail-safe, transcription-independent, suicide mechanism in acutely DNA-damaged cells: A hypothesis
89. Enhanced ligation of repair sites under conditions of inhibition of poly (ADP-ribose) synthesis by 3-aminobenzamide
90. Inhibition of malignant transformation in vitro by inhibitors of poly (ADP-ribose) synthesis
91. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase